Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4192.0
(-2.58%)
JPY 4192.0
(-2.58%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 171.62 Billion JPY | 3.18% |
| 2022 | 166.32 Billion JPY | 0.69% |
| 2021 | 165.18 Billion JPY | 1.13% |
| 2020 | 163.33 Billion JPY | 3.46% |
| 2019 | 157.87 Billion JPY | 1.21% |
| 2018 | 155.98 Billion JPY | 2.34% |
| 2017 | 152.41 Billion JPY | 12.85% |
| 2016 | 135.06 Billion JPY | 1.56% |
| 2015 | 132.99 Billion JPY | 15.51% |
| 2014 | 115.13 Billion JPY | 8.14% |
| 2013 | 106.46 Billion JPY | -2.25% |
| 2012 | 108.91 Billion JPY | 3.62% |
| 2011 | 105.1 Billion JPY | 6.72% |
| 2010 | 98.49 Billion JPY | 3.57% |
| 2009 | 95.09 Billion JPY | 0.63% |
| 2008 | 94.5 Billion JPY | 0.69% |
| 2007 | 93.85 Billion JPY | -6.98% |
| 2006 | 100.9 Billion JPY | 2.19% |
| 2005 | 98.73 Billion JPY | -9.04% |
| 2004 | 108.54 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 174.77 Billion JPY | 0.49% |
| 2023 FY | 171.62 Billion JPY | 3.18% |
| 2023 Q2 | 171.65 Billion JPY | 2.69% |
| 2023 Q1 | 167.15 Billion JPY | 0.49% |
| 2023 Q4 | 171.62 Billion JPY | 1.95% |
| 2023 Q3 | 168.33 Billion JPY | -1.93% |
| 2022 Q3 | 167.76 Billion JPY | 0.27% |
| 2022 Q2 | 167.3 Billion JPY | 1.34% |
| 2022 Q1 | 165.1 Billion JPY | -0.05% |
| 2022 FY | 166.32 Billion JPY | 0.69% |
| 2022 Q4 | 166.32 Billion JPY | -0.86% |
| 2021 Q4 | 165.18 Billion JPY | -1.49% |
| 2021 Q2 | 165.59 Billion JPY | 1.38% |
| 2021 FY | 165.18 Billion JPY | 1.13% |
| 2021 Q1 | 163.34 Billion JPY | 0.0% |
| 2021 Q3 | 167.67 Billion JPY | 1.26% |
| 2020 Q3 | 160.62 Billion JPY | -0.26% |
| 2020 Q1 | 158.34 Billion JPY | 0.3% |
| 2020 Q2 | 161.03 Billion JPY | 1.7% |
| 2020 Q4 | 163.33 Billion JPY | 1.68% |
| 2020 FY | 163.33 Billion JPY | 3.46% |
| 2019 Q4 | 157.87 Billion JPY | -1.67% |
| 2019 FY | 157.87 Billion JPY | 1.21% |
| 2019 Q3 | 160.55 Billion JPY | 3.92% |
| 2019 Q1 | 155.5 Billion JPY | -0.31% |
| 2019 Q2 | 154.49 Billion JPY | -0.65% |
| 2018 Q3 | 151.48 Billion JPY | -0.62% |
| 2018 Q4 | 155.98 Billion JPY | 2.97% |
| 2018 Q2 | 152.43 Billion JPY | 2.47% |
| 2018 Q1 | 148.76 Billion JPY | -2.4% |
| 2018 FY | 155.98 Billion JPY | 2.34% |
| 2017 Q2 | 148.59 Billion JPY | 6.97% |
| 2017 FY | 152.41 Billion JPY | 12.85% |
| 2017 Q4 | 152.41 Billion JPY | 1.74% |
| 2017 Q3 | 149.81 Billion JPY | 0.82% |
| 2017 Q1 | 138.9 Billion JPY | 2.85% |
| 2016 Q1 | 129.41 Billion JPY | -2.69% |
| 2016 Q4 | 135.06 Billion JPY | -1.49% |
| 2016 Q3 | 137.1 Billion JPY | 4.15% |
| 2016 Q2 | 131.64 Billion JPY | 1.73% |
| 2016 FY | 135.06 Billion JPY | 1.56% |
| 2015 Q3 | 136.14 Billion JPY | 9.53% |
| 2015 Q1 | 117.14 Billion JPY | 1.75% |
| 2015 Q4 | 132.99 Billion JPY | -2.32% |
| 2015 FY | 132.99 Billion JPY | 15.51% |
| 2015 Q2 | 124.29 Billion JPY | 6.11% |
| 2014 Q1 | 104.2 Billion JPY | -2.12% |
| 2014 FY | 115.13 Billion JPY | 8.14% |
| 2014 Q4 | 115.13 Billion JPY | -0.59% |
| 2014 Q2 | 106.19 Billion JPY | 1.91% |
| 2014 Q3 | 115.82 Billion JPY | 9.07% |
| 2013 FY | 106.46 Billion JPY | -2.25% |
| 2013 Q4 | 106.46 Billion JPY | 0.39% |
| 2013 Q3 | 106.05 Billion JPY | 4.26% |
| 2013 Q2 | 101.71 Billion JPY | -6.21% |
| 2013 Q1 | 108.45 Billion JPY | -0.42% |
| 2012 Q3 | 104.51 Billion JPY | -2.24% |
| 2012 Q4 | 108.91 Billion JPY | 4.21% |
| 2012 FY | 108.91 Billion JPY | 3.62% |
| 2012 Q2 | 106.9 Billion JPY | 5.12% |
| 2012 Q1 | 101.69 Billion JPY | -3.24% |
| 2011 Q3 | 102.67 Billion JPY | 5.6% |
| 2011 Q1 | 97.32 Billion JPY | -1.19% |
| 2011 Q2 | 97.23 Billion JPY | -0.1% |
| 2011 Q4 | 105.1 Billion JPY | 2.37% |
| 2011 FY | 105.1 Billion JPY | 6.72% |
| 2010 Q1 | 99.16 Billion JPY | 4.28% |
| 2010 Q2 | 96.43 Billion JPY | -2.75% |
| 2010 FY | 98.49 Billion JPY | 3.57% |
| 2010 Q3 | 102.59 Billion JPY | 6.39% |
| 2010 Q4 | 98.49 Billion JPY | -4.0% |
| 2009 FY | 95.09 Billion JPY | 0.63% |
| 2009 Q3 | 101.1 Billion JPY | 4.61% |
| 2009 Q4 | 95.09 Billion JPY | -5.94% |
| 2009 Q2 | 96.64 Billion JPY | 0.0% |
| 2008 Q4 | 94.5 Billion JPY | -3.07% |
| 2008 FY | 94.5 Billion JPY | 0.69% |
| 2008 Q3 | 97.49 Billion JPY | 0.0% |
| 2007 FY | 93.85 Billion JPY | -6.98% |
| 2006 FY | 100.9 Billion JPY | 2.19% |
| 2005 FY | 98.73 Billion JPY | -9.04% |
| 2004 FY | 108.54 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -369.261% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 98.864% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 81.088% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 87.888% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -1012.914% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 34.844% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 87.687% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -898.795% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 47.8% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | -8.075% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -124.461% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -246.377% |
| Tsumura & Co. | 428.25 Billion JPY | 59.925% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 34.226% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -28.622% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 60.148% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -101.124% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | -14.01% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 3.408% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -1040.655% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -120.856% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -1017.916% |
| MedRx Co., Ltd | 2.05 Billion JPY | -8263.694% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -805.742% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -6630.314% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -8371.34% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -83.924% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 55.075% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -3971.905% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 77.81% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -436.255% |